Skip to main content
SEARCH

How Covid-19 rocked the biosimilar market

In April 2020, just as the pandemic was starting to take full effect, the EMA had approved 58 biosimilars . It was a growing market, and the pandemic - and the inevitable economics constraints - actually brought biosimilars front and centre.

Following the 2008 recession, governments turned to biosimilars as a means of saving. Before long, the narrative around generics offering a lower efficacy rate was forgotten, and biosimilars were hailed as the answer to delivering effective healthcare solutions on a tighter budget. Although the market was in a unique position compared to other industries, it still faced many hurdles throughout the pandemic. Read on to hear how Covid-19 rocked the biosimilar market.

A challenge for companies focused on biosimilars

Over the years, several companies have started to distance their operations from the biosimilar market. Just take Merck, who have separated their biosimilars to be produced under the name of a different company. However, that does not mean to say there is lower competition. In fact, there are new companies on the scene, like Coherus Biosciences, which are snapping up newly available market share and establishing themselves as biosimilar-only businesses.

2020 marked the end of many blockbuster biologics patents in the US, such as Truvada, Chantix, Forteo, Ciprodex, and Afinitor. It was set to be a big year for the market, but for those focused on biosimilars, there were some obstacles to face.

Stagnation in the approval of non-Covid therapeutics

Before the outbreak of coronavirus, GlobalData found that 24% of survey respondents believed that ‘patent expiry of biologics’ was a top trend expected to have a positive impact on the pharmaceutical market . This was the most popular response, above M&A mega-deals and the vertical integration of the healthcare system. However, 2020 was the slowest year for approvals in the US market since 2016, with the FDA approving only three biosimilars . Many industry leaders have pointed out that this delay in the approval process has caused businesses to push back their launch dates, thereby flattening market growth.

Delays for products in the pipeline

When drugs lose patent protection, this creates new opportunities for biosimilar companies. A patent will typically last around 20 years from the moment a company files an application. This period gives exclusive rights to the drug inventor, after which competing companies can launch a biosimilar. Though the market was on track for a good year, the pandemic threatened to derail product pipelines. During the height of the outbreak, resources were diverted away from the research and development of new biosimilars and towards the fight against Covid-19 .

Logistical problems

In our report – The impact of biosimilar competition in Europe – we found that in 2020, biosimilar medicines reached a value of €8.4 billion, representing 9% of the total biologics market. But as the virus spread and operations were turned on their head, it soon became clear there would be a disruption to the supply chain. Raw materials could no longer reach their intended destination, and this brought the production of biosimilars to a grinding halt in some cases. But with a Covid-19 vaccine developed and deployed in record-breaking time, the market can breathe a sigh of relief knowing that these operations are steadily returning to normal.

Find your next job with IQVIA

It’s been a challenging year for biosimilar companies and the wider pharmaceutical industry, but there’s never been a better time to search for your next job. At IQVIA, we help our clients bring their biosimilar to market faster by tapping into unparalleled data, technology, advanced analytics, and scientific expertise. If you want to be a part of our mission, browse our e-detailing representative jobs and find out where you can take your biosimilar career with IQVIA. Or, browse all jobs to see what other job opportunities we can offer you.


im
List #1

IQVIA Related insights

Diana Heres - Service Development Executive at IQVIA Interface
What does career growth mean at IQVIA? Q&A with Diana Heres

Teaser

Medical Sales & Services

Content Type

Article

Published

24/10/2024

Summary

We caught up with Diana Heres, a Service Development Executive at IQVIA Interface, on her career development journey with us so far.  Diana shares her journey to help answer questions such as “How do

Teaser

Diana shares her journey to help answer questions such as “How do I build up my career?”

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Corinne Scott, Client Services Manager at IQVIA
Client Services Manager Corinne Scott shares her career change advice

Teaser

General

Content Type

Article

Published

08/10/2024

Summary

Recently, we interviewed Corinne Scott, Client Services Manager at IQVIA for her insight into how to decide a career change.  Corinne shared her own journey and valuable advice with us to help answer

Teaser

We interviewed Corinne Scott, Client Services Manager, for her insight on changing careers.

Read more
Corinne  Scott

by

Corinne Scott

Corinne  Scott

by

Corinne Scott

man typing at a laptop with a coffee next to his laptop.
What is a Virtual Sales Representative and how can you become one?

Teaser

Sales

Content Type

Article

Published

04/10/2024

Summary

Virtual Sales has a growing presence in the healthcare and medical solutions industry, especially since the pandemic. Virtual Sales is set to be the new normal, even as we’ve emerged on the other side

Teaser

Virtual Sales is set to be the new normal, even as we’ve emerged on the other side of COVID.

Read more
A clipboard on a table while two peoples arms are visible resting over it.
How do I explain my technical skills in an interview?

Teaser

General

Content Type

Article

Published

27/09/2024

Summary

Kickstarting or switching your career is only made easier by having solid technical skills under your belt. Technical skills are expertise and specialised knowledge that you enhance throughout your c

Teaser

Kickstarting or switching your career is only made easier by having solid technical skills.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

A laptop, notebook, and phone on a desk with a virtual image of Biological molecules.
What can you do with a biomedical science degree at IQVIA?

Teaser

Sales

Content Type

Article

Published

18/09/2024

Summary

If you’re a recent or soon-to-be graduate of biomedical science, and have realised that a laboratory-based career may not be the right direction for you, you may be wondering what other career opti

Teaser

Working in medical sales (or an allied role) could be a great choice to consider after graduating.

Read more
Tracey Smith

by

Tracey Smith

Tracey Smith

by

Tracey Smith

four hands, each holding a piece of a jigsaw, placing the pieces together.
The top 4 medical sales rep challenges and how to overcome them

Teaser

Medical Sales & Services

Content Type

Article

Published

17/09/2024

Summary

Stepping into any role in the healthcare sector comes with its challenges, and being a successful medical sales representative is no exception.  Whether you’re an experienced sales rep and feel confi

Teaser

Stepping into any role in the healthcare sector comes with its challenges

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

A man and a woman sat at a computer, both are wearing business-wear.
How to kickstart your medical affairs career

Teaser

Medical Affairs & Services

Content Type

Article

Published

13/08/2024

Summary

Medical Affairs is a fast-paced sector and the work is so varied that no two days will look the same.  Medical affairs professionals working in the pharmaceutical, biotechnology and medical device in

Teaser

Medical Affairs is a fast-paced sector and the work is so varied that no two days will look the same.

Read more
Medical technology concept - a virtual screen with med tech symbols.
The roles IQVIA offers in MedTech

Teaser

Medical Affairs & Services

Content Type

Article

Published

31/07/2024

Summary

At IQVIA, we recruit for various roles within the MedTech sphere and we’re always looking for professionals keen to move healthcare forward.  In this article, we’ll outline the market for MedTech so

Teaser

We’ve outlined just some of the field-based roles IQVIA has to offer in MedTech.

Read more
Tracey Smith

by

Tracey Smith

Tracey Smith

by

Tracey Smith

Some hands at a laptop with a virtual screen popping out of it showing data and trends.
What is the outlook for the global oncology market in 2024?

Teaser

Medical

Content Type

Article

Published

30/07/2024

Summary

In IQVIA, we support customers in their mission to get drugs to patients. As such, we recognise the value of keeping track of the latest market trends, developments, and insights.  Modern healthcare

Teaser

Oncology is just one example of a rapidly advancing field in 2024.

Read more
Catherine Scott

by

Catherine Scott

Catherine Scott

by

Catherine Scott

A lab setting with a clinician looking at a tablet.
What is clinical pharmacology?

Teaser

Clinical Operations

Content Type

Article

Published

23/07/2024

Summary

Clinical pharmacology, a specialised branch of biomedical science, holds a pivotal role in developing vital drugs and ensuring their effective use in patients.  Clinical pharmacologists bridge the ga

Teaser

Clinical pharmacology holds a pivotal role in developing vital drugs and ensuring their effective use in patients.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Smiling female executive making successful deal with partner shaking hand at work.
How to specialise in oncology sales

Teaser

Sales

Content Type

Article

Published

23/07/2024

Summary

Oncologists focus on diagnosing and treating cancer while overseeing treatment and managing post-treatment care. The oncology drugs market worldwide is expected to reach a market volume of $268bn by

Teaser

When it comes to medical sales, we dive into how you can specialise in oncology.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Group of three young coworkers working together in a sunny office.Man typing on computer keyboard. Woman pointing hand to desktop screen. Horizontal image, blurred background
What does a market access manager do and why should you become one?

Teaser

General

Content Type

Article

Published

17/07/2024

Summary

Market access is all about preparing a drug for market entry, and as such it’s a vitally important part of the drug development process and wider pharmaceutical industry. While for pharmaceutical an

Teaser

Market access is all about preparing a drug for market entry, and as such it’s a vitally important part of the drug development process and wider pharmaceutical industry.

Read more